View in EDS

The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.

Saved in:
Bibliographic Details
Title: The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
Authors: Scarisbrick JJ; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Member of the UK Cutaneous Lymphoma Group., Quaglino P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Prince HM; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Papadavid E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Hodak E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Bagot M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Servitje O; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Berti E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Ortiz-Romero P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Stadler R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Patsatsi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Knobler R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Guenova E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Child F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group., Whittaker S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Member of the UK Cutaneous Lymphoma Group., Nikolaou V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Tomasini C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Amitay I; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Prag Naveh H; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Ram-Wolff C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Battistella M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Alberti-Violetti S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Stranzenbach R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Gargallo V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Muniesa C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Koletsa T; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Jonak C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Porkert S; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Mitteldorf C; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Estrach T; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Combalia A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Marschalko M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Csomor J; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Szepesi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Cozzio A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Dummer R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Pimpinelli N; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Grandi V; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Beylot-Barry M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Pham-Ledard A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Wobser M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Geissinger E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Wehkamp U; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Weichenthal M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Cowan R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group., Parry E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group., Harris J; Member of the UK Cutaneous Lymphoma Group., Wachsmuth R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group., Turner D; Member of the UK Cutaneous Lymphoma Group., Bates A; Member of the UK Cutaneous Lymphoma Group., Healy E; Member of the UK Cutaneous Lymphoma Group., Trautinger F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Latzka J; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Yoo J; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Vydianath B; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K., Amel-Kashipaz R; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K., Marinos L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Oikonomidi A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Stratigos A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Vignon-Pennamen MD; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Battistella M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Climent F; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Gonzalez-Barca E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Georgiou E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Senetta R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Zinzani P; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Vakeva L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Ranki A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Busschots AM; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Hauben E; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Bervoets A; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Woei-A-Jin FJSH; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Matin R; Member of the UK Cutaneous Lymphoma Group., Collins G; Member of the UK Cutaneous Lymphoma Group., Weatherhead S; Member of the UK Cutaneous Lymphoma Group., Frew J; Member of the UK Cutaneous Lymphoma Group., Bayne M; Member of the UK Cutaneous Lymphoma Group., Dunnill G; Member of the UK Cutaneous Lymphoma Group., McKay P; Member of the UK Cutaneous Lymphoma Group., Arumainathan A; Member of the UK Cutaneous Lymphoma Group., Azurdia R; Member of the UK Cutaneous Lymphoma Group., Benstead K; Member of the UK Cutaneous Lymphoma Group., Twigger R; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Rieger K; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Brown R; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Sanches JA; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Miyashiro D; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Akilov O; Member of the Cutaneous Lymphoma International Consortium (CLIC)., McCann S; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Sahi H; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Damasco FM; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Querfeld C; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Folkes A; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Bur C; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Klemke CD; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Enz P; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Pujol R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Quint K; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Geskin L; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Hong E; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Evison F; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K., Vermeer M; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Cerroni L; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Kempf W; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force., Kim Y; Member of the Cutaneous Lymphoma International Consortium (CLIC)., Willemze R; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.
Source: The British journal of dermatology [Br J Dermatol] 2019 Aug; Vol. 181 (2), pp. 350-357. Date of Electronic Publication: 2018 Nov 25.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30267549
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Scarisbrick+JJ%22">Scarisbrick JJ</searchLink>; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Quaglino+P%22">Quaglino P</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Prince+HM%22">Prince HM</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Papadavid+E%22">Papadavid E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Hodak+E%22">Hodak E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Bagot+M%22">Bagot M</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Servitje+O%22">Servitje O</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Berti+E%22">Berti E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Ortiz-Romero+P%22">Ortiz-Romero P</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Stadler+R%22">Stadler R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Patsatsi+A%22">Patsatsi A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Knobler+R%22">Knobler R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Guenova+E%22">Guenova E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Child+F%22">Child F</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Whittaker+S%22">Whittaker S</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Nikolaou+V%22">Nikolaou V</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Tomasini+C%22">Tomasini C</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Amitay+I%22">Amitay I</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Prag+Naveh+H%22">Prag Naveh H</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Ram-Wolff+C%22">Ram-Wolff C</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Battistella+M%22">Battistella M</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Alberti-Violetti+S%22">Alberti-Violetti S</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Stranzenbach+R%22">Stranzenbach R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Gargallo+V%22">Gargallo V</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Muniesa+C%22">Muniesa C</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Koletsa+T%22">Koletsa T</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Jonak+C%22">Jonak C</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Porkert+S%22">Porkert S</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Mitteldorf+C%22">Mitteldorf C</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Estrach+T%22">Estrach T</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Combalia+A%22">Combalia A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Marschalko+M%22">Marschalko M</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Csomor+J%22">Csomor J</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Szepesi+A%22">Szepesi A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Cozzio+A%22">Cozzio A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Dummer+R%22">Dummer R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Pimpinelli+N%22">Pimpinelli N</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Grandi+V%22">Grandi V</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Beylot-Barry+M%22">Beylot-Barry M</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Pham-Ledard+A%22">Pham-Ledard A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Wobser+M%22">Wobser M</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Geissinger+E%22">Geissinger E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Wehkamp+U%22">Wehkamp U</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Weichenthal+M%22">Weichenthal M</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Cowan+R%22">Cowan R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Parry+E%22">Parry E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Harris+J%22">Harris J</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Wachsmuth+R%22">Wachsmuth R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Turner+D%22">Turner D</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Bates+A%22">Bates A</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Healy+E%22">Healy E</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Trautinger+F%22">Trautinger F</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Latzka+J%22">Latzka J</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Yoo+J%22">Yoo J</searchLink>; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Vydianath+B%22">Vydianath B</searchLink>; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.<br /><searchLink fieldCode="AU" term="%22Amel-Kashipaz+R%22">Amel-Kashipaz R</searchLink>; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.<br /><searchLink fieldCode="AU" term="%22Marinos+L%22">Marinos L</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Oikonomidi+A%22">Oikonomidi A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Stratigos+A%22">Stratigos A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Vignon-Pennamen+MD%22">Vignon-Pennamen MD</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Battistella+M%22">Battistella M</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Climent+F%22">Climent F</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Barca+E%22">Gonzalez-Barca E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Georgiou+E%22">Georgiou E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Senetta+R%22">Senetta R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Zinzani+P%22">Zinzani P</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Vakeva+L%22">Vakeva L</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Ranki+A%22">Ranki A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Busschots+AM%22">Busschots AM</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Hauben+E%22">Hauben E</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Bervoets+A%22">Bervoets A</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Woei-A-Jin+FJSH%22">Woei-A-Jin FJSH</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Matin+R%22">Matin R</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Collins+G%22">Collins G</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Weatherhead+S%22">Weatherhead S</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Frew+J%22">Frew J</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Bayne+M%22">Bayne M</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Dunnill+G%22">Dunnill G</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22McKay+P%22">McKay P</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Arumainathan+A%22">Arumainathan A</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Azurdia+R%22">Azurdia R</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Benstead+K%22">Benstead K</searchLink>; Member of the UK Cutaneous Lymphoma Group.<br /><searchLink fieldCode="AU" term="%22Twigger+R%22">Twigger R</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Rieger+K%22">Rieger K</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Brown+R%22">Brown R</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Sanches+JA%22">Sanches JA</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Miyashiro+D%22">Miyashiro D</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Akilov+O%22">Akilov O</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22McCann+S%22">McCann S</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Sahi+H%22">Sahi H</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Damasco+FM%22">Damasco FM</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Querfeld+C%22">Querfeld C</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Folkes+A%22">Folkes A</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Bur+C%22">Bur C</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Klemke+CD%22">Klemke CD</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Enz+P%22">Enz P</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Pujol+R%22">Pujol R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Quint+K%22">Quint K</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Geskin+L%22">Geskin L</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Hong+E%22">Hong E</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Evison+F%22">Evison F</searchLink>; European Co-ordinating PROCLIPI Centre for PROCLIPI, University Hospitals Birmingham, Birmingham, U.K.<br /><searchLink fieldCode="AU" term="%22Vermeer+M%22">Vermeer M</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Cerroni+L%22">Cerroni L</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Kempf+W%22">Kempf W</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Member of the Cutaneous Lymphoma International Consortium (CLIC).<br /><searchLink fieldCode="AU" term="%22Willemze+R%22">Willemze R</searchLink>; Member of the European Organisation of Research and Treatment of Cancer (EORTC), Cutaneous Lymphoma Task Force.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220004041%22">The British journal of dermatology</searchLink> [Br J Dermatol] 2019 Aug; Vol. 181 (2), pp. 350-357. <i>Date of Electronic Publication: </i>2018 Nov 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0004041 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2133 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070963%22">00070963 </searchLink><i>NLM ISO Abbreviation: </i>Br J Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30267549
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/bjd.17258
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 350
    Titles:
      – TitleFull: The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Scarisbrick JJ
      – PersonEntity:
          Name:
            NameFull: Quaglino P
      – PersonEntity:
          Name:
            NameFull: Prince HM
      – PersonEntity:
          Name:
            NameFull: Papadavid E
      – PersonEntity:
          Name:
            NameFull: Hodak E
      – PersonEntity:
          Name:
            NameFull: Bagot M
      – PersonEntity:
          Name:
            NameFull: Servitje O
      – PersonEntity:
          Name:
            NameFull: Berti E
      – PersonEntity:
          Name:
            NameFull: Ortiz-Romero P
      – PersonEntity:
          Name:
            NameFull: Stadler R
      – PersonEntity:
          Name:
            NameFull: Patsatsi A
      – PersonEntity:
          Name:
            NameFull: Knobler R
      – PersonEntity:
          Name:
            NameFull: Guenova E
      – PersonEntity:
          Name:
            NameFull: Child F
      – PersonEntity:
          Name:
            NameFull: Whittaker S
      – PersonEntity:
          Name:
            NameFull: Nikolaou V
      – PersonEntity:
          Name:
            NameFull: Tomasini C
      – PersonEntity:
          Name:
            NameFull: Amitay I
      – PersonEntity:
          Name:
            NameFull: Prag Naveh H
      – PersonEntity:
          Name:
            NameFull: Ram-Wolff C
      – PersonEntity:
          Name:
            NameFull: Battistella M
      – PersonEntity:
          Name:
            NameFull: Alberti-Violetti S
      – PersonEntity:
          Name:
            NameFull: Stranzenbach R
      – PersonEntity:
          Name:
            NameFull: Gargallo V
      – PersonEntity:
          Name:
            NameFull: Muniesa C
      – PersonEntity:
          Name:
            NameFull: Koletsa T
      – PersonEntity:
          Name:
            NameFull: Jonak C
      – PersonEntity:
          Name:
            NameFull: Porkert S
      – PersonEntity:
          Name:
            NameFull: Mitteldorf C
      – PersonEntity:
          Name:
            NameFull: Estrach T
      – PersonEntity:
          Name:
            NameFull: Combalia A
      – PersonEntity:
          Name:
            NameFull: Marschalko M
      – PersonEntity:
          Name:
            NameFull: Csomor J
      – PersonEntity:
          Name:
            NameFull: Szepesi A
      – PersonEntity:
          Name:
            NameFull: Cozzio A
      – PersonEntity:
          Name:
            NameFull: Dummer R
      – PersonEntity:
          Name:
            NameFull: Pimpinelli N
      – PersonEntity:
          Name:
            NameFull: Grandi V
      – PersonEntity:
          Name:
            NameFull: Beylot-Barry M
      – PersonEntity:
          Name:
            NameFull: Pham-Ledard A
      – PersonEntity:
          Name:
            NameFull: Wobser M
      – PersonEntity:
          Name:
            NameFull: Geissinger E
      – PersonEntity:
          Name:
            NameFull: Wehkamp U
      – PersonEntity:
          Name:
            NameFull: Weichenthal M
      – PersonEntity:
          Name:
            NameFull: Cowan R
      – PersonEntity:
          Name:
            NameFull: Parry E
      – PersonEntity:
          Name:
            NameFull: Harris J
      – PersonEntity:
          Name:
            NameFull: Wachsmuth R
      – PersonEntity:
          Name:
            NameFull: Turner D
      – PersonEntity:
          Name:
            NameFull: Bates A
      – PersonEntity:
          Name:
            NameFull: Healy E
      – PersonEntity:
          Name:
            NameFull: Trautinger F
      – PersonEntity:
          Name:
            NameFull: Latzka J
      – PersonEntity:
          Name:
            NameFull: Yoo J
      – PersonEntity:
          Name:
            NameFull: Vydianath B
      – PersonEntity:
          Name:
            NameFull: Amel-Kashipaz R
      – PersonEntity:
          Name:
            NameFull: Marinos L
      – PersonEntity:
          Name:
            NameFull: Oikonomidi A
      – PersonEntity:
          Name:
            NameFull: Stratigos A
      – PersonEntity:
          Name:
            NameFull: Vignon-Pennamen MD
      – PersonEntity:
          Name:
            NameFull: Battistella M
      – PersonEntity:
          Name:
            NameFull: Climent F
      – PersonEntity:
          Name:
            NameFull: Gonzalez-Barca E
      – PersonEntity:
          Name:
            NameFull: Georgiou E
      – PersonEntity:
          Name:
            NameFull: Senetta R
      – PersonEntity:
          Name:
            NameFull: Zinzani P
      – PersonEntity:
          Name:
            NameFull: Vakeva L
      – PersonEntity:
          Name:
            NameFull: Ranki A
      – PersonEntity:
          Name:
            NameFull: Busschots AM
      – PersonEntity:
          Name:
            NameFull: Hauben E
      – PersonEntity:
          Name:
            NameFull: Bervoets A
      – PersonEntity:
          Name:
            NameFull: Woei-A-Jin FJSH
      – PersonEntity:
          Name:
            NameFull: Matin R
      – PersonEntity:
          Name:
            NameFull: Collins G
      – PersonEntity:
          Name:
            NameFull: Weatherhead S
      – PersonEntity:
          Name:
            NameFull: Frew J
      – PersonEntity:
          Name:
            NameFull: Bayne M
      – PersonEntity:
          Name:
            NameFull: Dunnill G
      – PersonEntity:
          Name:
            NameFull: McKay P
      – PersonEntity:
          Name:
            NameFull: Arumainathan A
      – PersonEntity:
          Name:
            NameFull: Azurdia R
      – PersonEntity:
          Name:
            NameFull: Benstead K
      – PersonEntity:
          Name:
            NameFull: Twigger R
      – PersonEntity:
          Name:
            NameFull: Rieger K
      – PersonEntity:
          Name:
            NameFull: Brown R
      – PersonEntity:
          Name:
            NameFull: Sanches JA
      – PersonEntity:
          Name:
            NameFull: Miyashiro D
      – PersonEntity:
          Name:
            NameFull: Akilov O
      – PersonEntity:
          Name:
            NameFull: McCann S
      – PersonEntity:
          Name:
            NameFull: Sahi H
      – PersonEntity:
          Name:
            NameFull: Damasco FM
      – PersonEntity:
          Name:
            NameFull: Querfeld C
      – PersonEntity:
          Name:
            NameFull: Folkes A
      – PersonEntity:
          Name:
            NameFull: Bur C
      – PersonEntity:
          Name:
            NameFull: Klemke CD
      – PersonEntity:
          Name:
            NameFull: Enz P
      – PersonEntity:
          Name:
            NameFull: Pujol R
      – PersonEntity:
          Name:
            NameFull: Quint K
      – PersonEntity:
          Name:
            NameFull: Geskin L
      – PersonEntity:
          Name:
            NameFull: Hong E
      – PersonEntity:
          Name:
            NameFull: Evison F
      – PersonEntity:
          Name:
            NameFull: Vermeer M
      – PersonEntity:
          Name:
            NameFull: Cerroni L
      – PersonEntity:
          Name:
            NameFull: Kempf W
      – PersonEntity:
          Name:
            NameFull: Kim Y
      – PersonEntity:
          Name:
            NameFull: Willemze R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2019 Aug
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2133
          Numbering:
            – Type: volume
              Value: 181
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: The British journal of dermatology
              Type: main
ResultId 1